These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 33340617

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
    Wang C, Chen Z, Yi Y, Ding Y, Xu F, Kang H, Lin K, Shu X, Zhong Z, Zhang Z, Liu J, Xu Z, Liu L, He X, Chang Y, Zhao Q.
    Oncogene; 2024 Jan; 43(5):328-340. PubMed ID: 38040804
    [Abstract] [Full Text] [Related]

  • 6. DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.
    Feng T, Li S, Zhao G, Li Q, Yuan H, Zhang J, Gu R, Ou D, Guo Y, Kou Q, Wang Q, Li K, Lin P.
    Cell Oncol (Dordr); 2023 Oct; 46(5):1235-1252. PubMed ID: 37052853
    [Abstract] [Full Text] [Related]

  • 7. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4.
    Cui M, Xiao Z, Sun B, Wang Y, Zheng M, Ye L, Zhang X.
    Biochem Biophys Res Commun; 2014 Mar 14; 445(3):651-5. PubMed ID: 24576478
    [Abstract] [Full Text] [Related]

  • 8. Hepatocellular Carcinoma-Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element-Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth.
    Wang C, Tong Y, Wen Y, Cai J, Guo H, Huang L, Xu M, Feng M, Chen X, Zhang J, Wu H, Kong X, Xia Q.
    Hepatology; 2018 Nov 14; 68(5):1833-1850. PubMed ID: 29663480
    [Abstract] [Full Text] [Related]

  • 9. Sperm associated antigen 4 promotes SREBP1-mediated de novo lipogenesis via interaction with lamin A/C and contributes to tumor progression in hepatocellular carcinoma.
    Liu T, Yu J, Ge C, Zhao F, Chen J, Miao C, Jin W, Zhou Q, Geng Q, Lin H, Tian H, Chen T, Xie H, Cui Y, Yao M, Xiao X, Li J, Li H.
    Cancer Lett; 2022 Jun 28; 536():215642. PubMed ID: 35307486
    [Abstract] [Full Text] [Related]

  • 10. ACSL4 promotes malignant progression of Hepatocellular carcinoma by targeting PAK2 transcription.
    Wu D, Zuo Z, Sun X, Li X, Yin F, Yin W.
    Biochem Pharmacol; 2024 Jun 28; 224():116206. PubMed ID: 38615921
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma.
    Wang J, Wang Z, Yuan J, Wang J, Shen X.
    Aging (Albany NY); 2020 May 01; 12(9):7786-7800. PubMed ID: 32357142
    [Abstract] [Full Text] [Related]

  • 13. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
    Yu X, Lin Q, Wu Z, Zhang Y, Wang T, Zhao S, Song X, Chen C, Wang Z, Xu L, Li C, Gao L, Liang X, Yue X, Ma C.
    J Pathol; 2020 Dec 01; 252(4):358-370. PubMed ID: 32770671
    [Abstract] [Full Text] [Related]

  • 14. Acyl-CoA Synthetase Medium-Chain Family Member 5-Mediated Fatty Acid Metabolism Dysregulation Promotes the Progression of Hepatocellular Carcinoma.
    Yang L, Pham K, Xi Y, Jiang S, Robertson KD, Liu C.
    Am J Pathol; 2024 Oct 01; 194(10):1951-1966. PubMed ID: 39069168
    [Abstract] [Full Text] [Related]

  • 15. Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis.
    Meng H, Shen M, Li J, Zhang R, Li X, Zhao L, Huang G, Liu J.
    Eur J Pharmacol; 2021 Sep 05; 906():174280. PubMed ID: 34174265
    [Abstract] [Full Text] [Related]

  • 16. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK, Lung RW, Dawson CW, Young LS, Ko CW, Yeung WW, Kang W, To KF, Lo KW.
    J Pathol; 2018 Oct 05; 246(2):180-190. PubMed ID: 29968360
    [Abstract] [Full Text] [Related]

  • 17. Cholesterol attenuated the progression of DEN-induced hepatocellular carcinoma via inhibiting SCAP mediated fatty acid de novo synthesis.
    Zhao Z, Zhong L, He K, Qiu C, Li Z, Zhao L, Gong J.
    Biochem Biophys Res Commun; 2019 Feb 19; 509(4):855-861. PubMed ID: 30638930
    [Abstract] [Full Text] [Related]

  • 18. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
    Min X, Wen J, Zhao L, Wang K, Li Q, Huang G, Liu J, Zhao X.
    Mol Oncol; 2018 Sep 19; 12(9):1480-1497. PubMed ID: 30004626
    [Abstract] [Full Text] [Related]

  • 19. Acyl-CoA thioesterase 9 promotes tumour growth and metastasis through reprogramming of fatty acid metabolism in hepatocellular carcinoma.
    Wang B, Zhang H, Chen YF, Hu LQ, Tian YY, Tong HW, Wang G, Chen C, Yuan P.
    Liver Int; 2022 Nov 19; 42(11):2548-2561. PubMed ID: 36004563
    [Abstract] [Full Text] [Related]

  • 20. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
    Liu Y, Ren H, Zhou Y, Shang L, Zhang Y, Yang F, Shi X.
    J Exp Clin Cancer Res; 2019 May 29; 38(1):228. PubMed ID: 31142342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.